glp-1 type 1 diabetes Receptor Agonists as Treatments for 2 GLP-1s are no longer the

Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake

2026;DOI:10.1016/S0140-6736(26)00202-3

This has led to increasing scientific interest in incretin hormones and incretin interactions, and several compounds based on dual- and multi-agonists are now being investigated for the treatment of metabolic diseases

Consequently, healthcare reimbursement for GLP-1 medications is pivotal in driving their adoption and utilization within clinical practice by enhancing affordability, widening access to treatment, and influencing physician prescribing patterns in the market

Its difficult for some dermatologists to pick up on race-specific hair loss because the nuances arent readily known throughout the medical community, according to Crystal Aguh, MD, associate professor of dermatology and director of the Ethnic Skin Program at Johns Hopkins School of Medicine: We need to incorporate [conditions specific to textured hair] into our training and textbooks and make them a standard part of the curriculum. Familiarity with Black hair culture also plays a role in treating hair loss in women of color

How Illness Affects Your GLP-1 Response and Weight Loss Progress A pause of one to two weeks during COVID-19 will not erase your weight loss progress or reset your metabolism